Provided by Tiger Trade Technology Pte. Ltd.

enVVeno Medical Corp.

10.66
+0.37003.60%
Volume:16.73K
Turnover:178.99K
Market Cap:7.28M
PE:-0.43
High:11.41
Open:10.59
Low:10.30
Close:10.29
52wk High:36.05
52wk Low:8.67
Shares:682.70K
Float Shares:563.60K
Volume Ratio:1.11
T/O Rate:2.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-24.8994
EPS(LYR):-33.0600
ROE:-58.53%
ROA:-36.67%
PB:0.35
PE(LYR):-0.32

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 31, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 14, 2026

Major Issues Report

Form 8-K - Current report
Jun 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2026

Major Issues Report

Form 8-K - Current report
Mar 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2026

Major Issues Report

Form 8-K - Current report
Jan 20, 2026

Major Issues Report

Form 8-K - Current report
Dec 12, 2025

Major Issues Report

Form 8-K - Current report
Nov 20, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2025

Major Issues Report

Form 8-K - Current report
Oct 30, 2025

Major Issues Report

Form 8-K - Current report
Oct 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 10, 2025

Major Issues Report

Form 8-K - Current report
Sep 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities